JP2006512924A - 脳内皮細胞発現パターン - Google Patents
脳内皮細胞発現パターン Download PDFInfo
- Publication number
- JP2006512924A JP2006512924A JP2005502059A JP2005502059A JP2006512924A JP 2006512924 A JP2006512924 A JP 2006512924A JP 2005502059 A JP2005502059 A JP 2005502059A JP 2005502059 A JP2005502059 A JP 2005502059A JP 2006512924 A JP2006512924 A JP 2006512924A
- Authority
- JP
- Japan
- Prior art keywords
- protein
- gene
- homo sapiens
- factor
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000014509 gene expression Effects 0.000 title claims abstract description 95
- 210000002889 endothelial cell Anatomy 0.000 title abstract description 67
- 210000004556 brain Anatomy 0.000 title abstract description 48
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 330
- 241000282414 Homo sapiens Species 0.000 claims abstract description 186
- 238000000034 method Methods 0.000 claims abstract description 103
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 78
- 210000001519 tissue Anatomy 0.000 claims abstract description 36
- 210000003038 endothelium Anatomy 0.000 claims abstract description 11
- 235000018102 proteins Nutrition 0.000 claims description 176
- 102000004169 proteins and genes Human genes 0.000 claims description 176
- 239000002299 complementary DNA Substances 0.000 claims description 103
- 206010018338 Glioma Diseases 0.000 claims description 91
- 108020004999 messenger RNA Proteins 0.000 claims description 82
- 208000032612 Glial tumor Diseases 0.000 claims description 81
- 210000004027 cell Anatomy 0.000 claims description 73
- 101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 claims description 38
- 230000003511 endothelial effect Effects 0.000 claims description 38
- 210000005013 brain tissue Anatomy 0.000 claims description 32
- 102000005962 receptors Human genes 0.000 claims description 31
- 108020003175 receptors Proteins 0.000 claims description 31
- 102100022002 CD59 glycoprotein Human genes 0.000 claims description 30
- 230000027455 binding Effects 0.000 claims description 30
- 239000000427 antigen Substances 0.000 claims description 28
- 108091007433 antigens Proteins 0.000 claims description 28
- 102000036639 antigens Human genes 0.000 claims description 28
- 239000012528 membrane Substances 0.000 claims description 28
- 238000012360 testing method Methods 0.000 claims description 28
- 102000014914 Carrier Proteins Human genes 0.000 claims description 26
- 108091008324 binding proteins Proteins 0.000 claims description 26
- 101000629921 Homo sapiens Translocon-associated protein subunit delta Proteins 0.000 claims description 22
- 102100026226 Translocon-associated protein subunit delta Human genes 0.000 claims description 22
- 150000007523 nucleic acids Chemical class 0.000 claims description 22
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 claims description 21
- 150000001875 compounds Chemical class 0.000 claims description 21
- 102000039446 nucleic acids Human genes 0.000 claims description 20
- 108020004707 nucleic acids Proteins 0.000 claims description 20
- 210000004369 blood Anatomy 0.000 claims description 18
- 239000008280 blood Substances 0.000 claims description 18
- 108010025821 lamin C Proteins 0.000 claims description 18
- 102100022145 Collagen alpha-1(IV) chain Human genes 0.000 claims description 17
- 101000901150 Homo sapiens Collagen alpha-1(IV) chain Proteins 0.000 claims description 17
- 108010052285 Membrane Proteins Proteins 0.000 claims description 17
- 108700020796 Oncogene Proteins 0.000 claims description 17
- 102100030511 Stanniocalcin-1 Human genes 0.000 claims description 17
- 101710142157 Stanniocalcin-1 Proteins 0.000 claims description 17
- 241000700605 Viruses Species 0.000 claims description 17
- 210000000170 cell membrane Anatomy 0.000 claims description 17
- 101000642514 Homo sapiens Transcription factor SOX-4 Proteins 0.000 claims description 16
- 102000018697 Membrane Proteins Human genes 0.000 claims description 16
- 102100036693 Transcription factor SOX-4 Human genes 0.000 claims description 16
- 102100033725 Tumor necrosis factor receptor superfamily member 16 Human genes 0.000 claims description 16
- 230000006698 induction Effects 0.000 claims description 16
- 239000003550 marker Substances 0.000 claims description 16
- 208000011580 syndromic disease Diseases 0.000 claims description 16
- 102100036597 Basement membrane-specific heparan sulfate proteoglycan core protein Human genes 0.000 claims description 15
- 108010021099 Lamin Type A Proteins 0.000 claims description 15
- 102000008201 Lamin Type A Human genes 0.000 claims description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 15
- 201000001441 melanoma Diseases 0.000 claims description 15
- 102100028239 Basal cell adhesion molecule Human genes 0.000 claims description 14
- 102100039554 Galectin-8 Human genes 0.000 claims description 14
- 101000935638 Homo sapiens Basal cell adhesion molecule Proteins 0.000 claims description 14
- 101000608769 Homo sapiens Galectin-8 Proteins 0.000 claims description 14
- 101000801254 Homo sapiens Tumor necrosis factor receptor superfamily member 16 Proteins 0.000 claims description 14
- 108010001127 Insulin Receptor Proteins 0.000 claims description 14
- 102000001776 Matrix metalloproteinase-9 Human genes 0.000 claims description 14
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 claims description 14
- 102100037081 Scavenger receptor class F member 1 Human genes 0.000 claims description 14
- 239000003446 ligand Substances 0.000 claims description 14
- 230000036961 partial effect Effects 0.000 claims description 14
- 108010049224 perlecan Proteins 0.000 claims description 14
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 claims description 13
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 claims description 13
- 230000002950 deficient Effects 0.000 claims description 13
- 239000003814 drug Substances 0.000 claims description 13
- 239000002243 precursor Substances 0.000 claims description 13
- 102000008490 2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine Human genes 0.000 claims description 12
- 102000016917 Complement C1 Human genes 0.000 claims description 12
- 108010028774 Complement C1 Proteins 0.000 claims description 12
- 102000010180 Endothelin receptor Human genes 0.000 claims description 12
- 108050001739 Endothelin receptor Proteins 0.000 claims description 12
- 101000904594 Homo sapiens Beta-1,3-galactosyltransferase 6 Proteins 0.000 claims description 12
- 101001067187 Homo sapiens Plexin-A2 Proteins 0.000 claims description 12
- 101000651018 Homo sapiens Splicing factor, proline- and glutamine-rich Proteins 0.000 claims description 12
- 108010041014 Integrin alpha5 Proteins 0.000 claims description 12
- 102100028241 MAP7 domain-containing protein 1 Human genes 0.000 claims description 12
- 108010076557 Matrix Metalloproteinase 14 Proteins 0.000 claims description 12
- 102100030216 Matrix metalloproteinase-14 Human genes 0.000 claims description 12
- 208000003445 Mouth Neoplasms Diseases 0.000 claims description 12
- 102100034539 Peptidyl-prolyl cis-trans isomerase A Human genes 0.000 claims description 12
- 102100034381 Plexin-A2 Human genes 0.000 claims description 12
- 102100022982 Procollagen galactosyltransferase 1 Human genes 0.000 claims description 12
- 102100027780 Splicing factor, proline- and glutamine-rich Human genes 0.000 claims description 12
- 102000006467 TATA-Box Binding Protein Human genes 0.000 claims description 12
- 108010044281 TATA-Box Binding Protein Proteins 0.000 claims description 12
- 102100034917 Testis-specific Y-encoded-like protein 2 Human genes 0.000 claims description 12
- 101710200531 Testis-specific Y-encoded-like protein 2 Proteins 0.000 claims description 12
- 235000018417 cysteine Nutrition 0.000 claims description 12
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 12
- 230000001939 inductive effect Effects 0.000 claims description 12
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 claims description 12
- 229920001184 polypeptide Polymers 0.000 claims description 12
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 12
- 102100040278 E3 ubiquitin-protein ligase RNF19A Human genes 0.000 claims description 11
- 101710157279 E3 ubiquitin-protein ligase RNF19A Proteins 0.000 claims description 11
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims description 11
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims description 11
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 11
- 208000008732 thymoma Diseases 0.000 claims description 11
- 102000003390 tumor necrosis factor Human genes 0.000 claims description 11
- 102000004888 Aquaporin 1 Human genes 0.000 claims description 10
- 108090001004 Aquaporin 1 Proteins 0.000 claims description 10
- 108010042086 Collagen Type IV Proteins 0.000 claims description 10
- 102000004266 Collagen Type IV Human genes 0.000 claims description 10
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 claims description 10
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 claims description 10
- 101001067170 Homo sapiens Plexin-B2 Proteins 0.000 claims description 10
- 108010053291 Oncogene Protein v-akt Proteins 0.000 claims description 10
- 102100034383 Plexin-B2 Human genes 0.000 claims description 10
- 102000037054 SLC-Transporter Human genes 0.000 claims description 10
- 108091006207 SLC-Transporter Proteins 0.000 claims description 10
- 230000001419 dependent effect Effects 0.000 claims description 10
- 239000012634 fragment Substances 0.000 claims description 10
- 102000015585 poly-pyrimidine tract binding protein Human genes 0.000 claims description 10
- 108010063723 poly-pyrimidine tract binding protein Proteins 0.000 claims description 10
- 102100034613 Annexin A2 Human genes 0.000 claims description 9
- 108090000668 Annexin A2 Proteins 0.000 claims description 9
- 102000009333 Apolipoprotein D Human genes 0.000 claims description 9
- 108010025614 Apolipoproteins D Proteins 0.000 claims description 9
- 102000004168 Dysferlin Human genes 0.000 claims description 9
- 108090000620 Dysferlin Proteins 0.000 claims description 9
- 101000903686 Homo sapiens Procollagen galactosyltransferase 1 Proteins 0.000 claims description 9
- 101000755529 Homo sapiens Transforming protein RhoA Proteins 0.000 claims description 9
- 102000004856 Lectins Human genes 0.000 claims description 9
- 108090001090 Lectins Proteins 0.000 claims description 9
- 102000012750 Membrane Glycoproteins Human genes 0.000 claims description 9
- 108010090054 Membrane Glycoproteins Proteins 0.000 claims description 9
- 102000009203 Sema domains Human genes 0.000 claims description 9
- 108050000099 Sema domains Proteins 0.000 claims description 9
- 102100022387 Transforming protein RhoA Human genes 0.000 claims description 9
- 230000004069 differentiation Effects 0.000 claims description 9
- 239000002523 lectin Substances 0.000 claims description 9
- 150000002632 lipids Chemical class 0.000 claims description 9
- 108010047303 von Willebrand Factor Proteins 0.000 claims description 9
- 102100036537 von Willebrand factor Human genes 0.000 claims description 9
- 102100032605 Adhesion G protein-coupled receptor B1 Human genes 0.000 claims description 8
- 101710096306 Adhesion G protein-coupled receptor B1 Proteins 0.000 claims description 8
- 102100022014 Angiopoietin-1 receptor Human genes 0.000 claims description 8
- 102000002734 Collagen Type VI Human genes 0.000 claims description 8
- 108010043741 Collagen Type VI Proteins 0.000 claims description 8
- 102100031544 Collagen alpha-1(XXVII) chain Human genes 0.000 claims description 8
- 108020004414 DNA Proteins 0.000 claims description 8
- 102000002090 Fibronectin type III Human genes 0.000 claims description 8
- 102100040510 Galectin-3-binding protein Human genes 0.000 claims description 8
- 102100028971 HLA class I histocompatibility antigen, C alpha chain Human genes 0.000 claims description 8
- 102100028006 Heme oxygenase 1 Human genes 0.000 claims description 8
- 101000753291 Homo sapiens Angiopoietin-1 receptor Proteins 0.000 claims description 8
- 101000940372 Homo sapiens Collagen alpha-1(XXVII) chain Proteins 0.000 claims description 8
- 101000967904 Homo sapiens Galectin-3-binding protein Proteins 0.000 claims description 8
- 101000986084 Homo sapiens HLA class I histocompatibility antigen, C alpha chain Proteins 0.000 claims description 8
- 101001079623 Homo sapiens Heme oxygenase 1 Proteins 0.000 claims description 8
- 101000972488 Homo sapiens Laminin subunit alpha-4 Proteins 0.000 claims description 8
- 101001008527 Homo sapiens Laminin subunit alpha-5 Proteins 0.000 claims description 8
- 101001023261 Homo sapiens Laminin subunit gamma-3 Proteins 0.000 claims description 8
- 101001043352 Homo sapiens Lysyl oxidase homolog 2 Proteins 0.000 claims description 8
- 101001094868 Homo sapiens Plexin-D1 Proteins 0.000 claims description 8
- 101000635804 Homo sapiens Tissue factor Proteins 0.000 claims description 8
- 102000012334 Integrin beta4 Human genes 0.000 claims description 8
- 108010022238 Integrin beta4 Proteins 0.000 claims description 8
- 102100022743 Laminin subunit alpha-4 Human genes 0.000 claims description 8
- 102100027450 Laminin subunit alpha-5 Human genes 0.000 claims description 8
- 102100035158 Laminin subunit gamma-3 Human genes 0.000 claims description 8
- 102100021948 Lysyl oxidase homolog 2 Human genes 0.000 claims description 8
- 108010044843 Peptide Initiation Factors Proteins 0.000 claims description 8
- 102000005877 Peptide Initiation Factors Human genes 0.000 claims description 8
- 102100035380 Plexin-D1 Human genes 0.000 claims description 8
- 102100036197 Prosaposin Human genes 0.000 claims description 8
- 101710152403 Prosaposin Proteins 0.000 claims description 8
- 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 claims description 8
- 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 claims description 8
- 108091015661 Scavenger receptor class F member 1 Proteins 0.000 claims description 8
- 102100028848 Stromelysin-2 Human genes 0.000 claims description 8
- 102100030859 Tissue factor Human genes 0.000 claims description 8
- 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 claims description 8
- 239000002246 antineoplastic agent Substances 0.000 claims description 8
- -1 clone IMAGE: 3342825 Proteins 0.000 claims description 8
- 239000003623 enhancer Substances 0.000 claims description 8
- 238000003780 insertion Methods 0.000 claims description 8
- 230000037431 insertion Effects 0.000 claims description 8
- 210000003712 lysosome Anatomy 0.000 claims description 8
- 230000001868 lysosomic effect Effects 0.000 claims description 8
- 102000037831 nucleoside transporters Human genes 0.000 claims description 8
- 108091006527 nucleoside transporters Proteins 0.000 claims description 8
- 102000003298 tumor necrosis factor receptor Human genes 0.000 claims description 8
- 102000004954 Biglycan Human genes 0.000 claims description 7
- 108090001138 Biglycan Proteins 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 7
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 claims description 7
- 108091026890 Coding region Proteins 0.000 claims description 7
- 102000029816 Collagenase Human genes 0.000 claims description 7
- 108060005980 Collagenase Proteins 0.000 claims description 7
- 102000010970 Connexin Human genes 0.000 claims description 7
- 108050001175 Connexin Proteins 0.000 claims description 7
- 102100038083 Endosialin Human genes 0.000 claims description 7
- 101000916414 Homo sapiens Calsyntenin-3 Proteins 0.000 claims description 7
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 claims description 7
- 108090000965 Insulin-like growth factor binding protein 3 Proteins 0.000 claims description 7
- 102100022708 Insulin-like growth factor-binding protein 3 Human genes 0.000 claims description 7
- 102100029228 Insulin-like growth factor-binding protein 7 Human genes 0.000 claims description 7
- 108700003486 Jagged-1 Proteins 0.000 claims description 7
- 102000009073 Macrophage Migration-Inhibitory Factors Human genes 0.000 claims description 7
- 108010048043 Macrophage Migration-Inhibitory Factors Proteins 0.000 claims description 7
- 108050008953 Melanoma-associated antigen Proteins 0.000 claims description 7
- 241001529936 Murinae Species 0.000 claims description 7
- 101001027130 Mus musculus Fibronectin Proteins 0.000 claims description 7
- 108091000080 Phosphotransferase Proteins 0.000 claims description 7
- 102000004885 Protease-activated receptor 4 Human genes 0.000 claims description 7
- 108090001010 Protease-activated receptor 4 Proteins 0.000 claims description 7
- 102100032702 Protein jagged-1 Human genes 0.000 claims description 7
- 108700037966 Protein jagged-1 Proteins 0.000 claims description 7
- 102100040952 Tetraspanin-7 Human genes 0.000 claims description 7
- 101710151639 Tetraspanin-7 Proteins 0.000 claims description 7
- 102100026497 Zinc finger protein 654 Human genes 0.000 claims description 7
- 230000000692 anti-sense effect Effects 0.000 claims description 7
- 238000003556 assay Methods 0.000 claims description 7
- 230000015572 biosynthetic process Effects 0.000 claims description 7
- 239000011575 calcium Substances 0.000 claims description 7
- 229910052791 calcium Inorganic materials 0.000 claims description 7
- 150000001720 carbohydrates Chemical class 0.000 claims description 7
- 229960002424 collagenase Drugs 0.000 claims description 7
- 238000009396 hybridization Methods 0.000 claims description 7
- 230000028993 immune response Effects 0.000 claims description 7
- 239000003112 inhibitor Substances 0.000 claims description 7
- 108010008598 insulin-like growth factor binding protein-related protein 1 Proteins 0.000 claims description 7
- 102000006495 integrins Human genes 0.000 claims description 7
- 108010044426 integrins Proteins 0.000 claims description 7
- 230000002438 mitochondrial effect Effects 0.000 claims description 7
- 102000020233 phosphotransferase Human genes 0.000 claims description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 6
- 108010020504 2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine Proteins 0.000 claims description 6
- 102100031571 40S ribosomal protein S16 Human genes 0.000 claims description 6
- 102100033051 40S ribosomal protein S19 Human genes 0.000 claims description 6
- 102100038686 5'-nucleotidase domain-containing protein 2 Human genes 0.000 claims description 6
- 102100021546 60S ribosomal protein L10 Human genes 0.000 claims description 6
- 102100025601 60S ribosomal protein L27 Human genes 0.000 claims description 6
- 102100030982 60S ribosomal protein L38 Human genes 0.000 claims description 6
- 201000011374 Alagille syndrome Diseases 0.000 claims description 6
- 102100038471 Ankycorbin Human genes 0.000 claims description 6
- 102100029470 Apolipoprotein E Human genes 0.000 claims description 6
- 101710095339 Apolipoprotein E Proteins 0.000 claims description 6
- 102000007592 Apolipoproteins Human genes 0.000 claims description 6
- 108010071619 Apolipoproteins Proteins 0.000 claims description 6
- 102100023579 Autophagy-related protein 2 homolog A Human genes 0.000 claims description 6
- 108010077173 BB Form Creatine Kinase Proteins 0.000 claims description 6
- 102100023994 Beta-1,3-galactosyltransferase 6 Human genes 0.000 claims description 6
- 102100032954 C2 domain-containing protein 2 Human genes 0.000 claims description 6
- 102100038078 CD276 antigen Human genes 0.000 claims description 6
- 101710185679 CD276 antigen Proteins 0.000 claims description 6
- 102100036158 Ceramide kinase Human genes 0.000 claims description 6
- 102000019034 Chemokines Human genes 0.000 claims description 6
- 108010012236 Chemokines Proteins 0.000 claims description 6
- 102100027466 Cofilin-1 Human genes 0.000 claims description 6
- 102000001045 Connexin 43 Human genes 0.000 claims description 6
- 108010069241 Connexin 43 Proteins 0.000 claims description 6
- 102100022785 Creatine kinase B-type Human genes 0.000 claims description 6
- 108010072220 Cyclophilin A Proteins 0.000 claims description 6
- 102100026897 Cystatin-C Human genes 0.000 claims description 6
- 102100031621 Cysteine and glycine-rich protein 2 Human genes 0.000 claims description 6
- 101710185482 Cysteine and glycine-rich protein 2 Proteins 0.000 claims description 6
- 102100021903 Cysteine protease ATG4B Human genes 0.000 claims description 6
- 101710202823 Cysteine-rich protein 2 Proteins 0.000 claims description 6
- 102100035149 Cytosolic endo-beta-N-acetylglucosaminidase Human genes 0.000 claims description 6
- 102000010170 Death domains Human genes 0.000 claims description 6
- 108050001718 Death domains Proteins 0.000 claims description 6
- 102100024425 Dihydropyrimidinase-related protein 3 Human genes 0.000 claims description 6
- 108700020492 Drosophila E Proteins 0.000 claims description 6
- 108700019125 Drosophila Em7-HLH Proteins 0.000 claims description 6
- 102100032248 Dysferlin Human genes 0.000 claims description 6
- 102100021739 E3 ubiquitin-protein ligase BRE1B Human genes 0.000 claims description 6
- 101710089902 E3 ubiquitin-protein ligase BRE1B Proteins 0.000 claims description 6
- 101710144543 Endosialin Proteins 0.000 claims description 6
- 102100037255 Equilibrative nucleobase transporter 1 Human genes 0.000 claims description 6
- 206010049466 Erythroblastosis Diseases 0.000 claims description 6
- 102000018700 F-Box Proteins Human genes 0.000 claims description 6
- 108010066805 F-Box Proteins Proteins 0.000 claims description 6
- 102100026536 Fibronectin type III domain-containing protein 4 Human genes 0.000 claims description 6
- 101710102119 GTP-binding protein 2 Proteins 0.000 claims description 6
- 208000017462 Galactosialidosis Diseases 0.000 claims description 6
- 241000287828 Gallus gallus Species 0.000 claims description 6
- 102000013382 Gelatinases Human genes 0.000 claims description 6
- 108010026132 Gelatinases Proteins 0.000 claims description 6
- 102100023849 Glycophorin-C Human genes 0.000 claims description 6
- 102100028085 Glycylpeptide N-tetradecanoyltransferase 1 Human genes 0.000 claims description 6
- 101710161767 Golgi resident protein GCP60 Proteins 0.000 claims description 6
- 102100033415 Golgi resident protein GCP60 Human genes 0.000 claims description 6
- 102100028541 Guanylate-binding protein 2 Human genes 0.000 claims description 6
- 101710110789 Guanylate-binding protein 2 Proteins 0.000 claims description 6
- 102100028976 HLA class I histocompatibility antigen, B alpha chain Human genes 0.000 claims description 6
- 101710142296 HLA class I histocompatibility antigen, B alpha chain Proteins 0.000 claims description 6
- 102100027618 Heme transporter HRG1 Human genes 0.000 claims description 6
- 102100027711 Histone-lysine N-methyltransferase SETD5 Human genes 0.000 claims description 6
- 101000604533 Homo sapiens 5'-nucleotidase domain-containing protein 2 Proteins 0.000 claims description 6
- 101001127039 Homo sapiens 60S ribosomal protein L38 Proteins 0.000 claims description 6
- 101001099918 Homo sapiens Ankycorbin Proteins 0.000 claims description 6
- 101000905707 Homo sapiens Autophagy-related protein 2 homolog A Proteins 0.000 claims description 6
- 101000867968 Homo sapiens C2 domain-containing protein 2 Proteins 0.000 claims description 6
- 101000715694 Homo sapiens Centrosomal protein of 170 kDa Proteins 0.000 claims description 6
- 101000725583 Homo sapiens Cofilin-1 Proteins 0.000 claims description 6
- 101000912205 Homo sapiens Cystatin-C Proteins 0.000 claims description 6
- 101000753468 Homo sapiens Cysteine protease ATG4B Proteins 0.000 claims description 6
- 101001053501 Homo sapiens Dihydropyrimidinase-related protein 3 Proteins 0.000 claims description 6
- 101001016184 Homo sapiens Dysferlin Proteins 0.000 claims description 6
- 101000664993 Homo sapiens E3 ubiquitin-protein ligase SMURF1 Proteins 0.000 claims description 6
- 101000905336 Homo sapiens Glycophorin-C Proteins 0.000 claims description 6
- 101000578329 Homo sapiens Glycylpeptide N-tetradecanoyltransferase 1 Proteins 0.000 claims description 6
- 101001045848 Homo sapiens Histone-lysine N-methyltransferase 2B Proteins 0.000 claims description 6
- 101000633984 Homo sapiens Influenza virus NS1A-binding protein Proteins 0.000 claims description 6
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 claims description 6
- 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 claims description 6
- 101000615505 Homo sapiens Methyl-CpG-binding domain protein 6 Proteins 0.000 claims description 6
- 101000573220 Homo sapiens NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 Proteins 0.000 claims description 6
- 101000983294 Homo sapiens Oligosaccharyltransferase complex subunit OSTC Proteins 0.000 claims description 6
- 101100489133 Homo sapiens PRO0628 gene Proteins 0.000 claims description 6
- 101000597240 Homo sapiens Pleckstrin homology-like domain family B member 1 Proteins 0.000 claims description 6
- 101000821885 Homo sapiens Protein S100-B Proteins 0.000 claims description 6
- 101000780643 Homo sapiens Protein argonaute-2 Proteins 0.000 claims description 6
- 101000927796 Homo sapiens Rho guanine nucleotide exchange factor 7 Proteins 0.000 claims description 6
- 101000588007 Homo sapiens SPARC-like protein 1 Proteins 0.000 claims description 6
- 101000663183 Homo sapiens Scavenger receptor class F member 1 Proteins 0.000 claims description 6
- 101000654676 Homo sapiens Semaphorin-6B Proteins 0.000 claims description 6
- 101001041393 Homo sapiens Serine protease HTRA1 Proteins 0.000 claims description 6
- 101001095381 Homo sapiens Serine/threonine-protein phosphatase 6 regulatory subunit 2 Proteins 0.000 claims description 6
- 101000835720 Homo sapiens Transcription elongation factor A protein 1 Proteins 0.000 claims description 6
- 101000653538 Homo sapiens Transcription factor 25 Proteins 0.000 claims description 6
- 101000715062 Homo sapiens Transcription initiation factor TFIID subunit 11 Proteins 0.000 claims description 6
- 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 claims description 6
- 101001000095 Homo sapiens Unconventional myosin-Id Proteins 0.000 claims description 6
- 101000585623 Homo sapiens Unconventional myosin-X Proteins 0.000 claims description 6
- 102100039285 Hyaluronidase-2 Human genes 0.000 claims description 6
- 101710199674 Hyaluronidase-2 Proteins 0.000 claims description 6
- 102100029241 Influenza virus NS1A-binding protein Human genes 0.000 claims description 6
- 102000004371 Insulin-like growth factor binding protein 5 Human genes 0.000 claims description 6
- 108090000961 Insulin-like growth factor binding protein 5 Proteins 0.000 claims description 6
- 102100032817 Integrin alpha-5 Human genes 0.000 claims description 6
- 108010042918 Integrin alpha5beta1 Proteins 0.000 claims description 6
- 102100025304 Integrin beta-1 Human genes 0.000 claims description 6
- 102100024307 MICAL-like protein 2 Human genes 0.000 claims description 6
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 claims description 6
- 102100021281 Methyl-CpG-binding domain protein 6 Human genes 0.000 claims description 6
- 102100025207 Mitogen-activated protein kinase kinase kinase 11 Human genes 0.000 claims description 6
- 101100519086 Mus musculus Pcgf2 gene Proteins 0.000 claims description 6
- 102100026374 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 Human genes 0.000 claims description 6
- 102100026241 Oligosaccharyltransferase complex subunit OSTC Human genes 0.000 claims description 6
- 101710111198 Peptidyl-prolyl cis-trans isomerase A Proteins 0.000 claims description 6
- 102100023410 Phospholipid hydroperoxide glutathione peroxidase Human genes 0.000 claims description 6
- 102100030832 Pleckstrin homology domain-containing family J member 1 Human genes 0.000 claims description 6
- 102100035150 Pleckstrin homology-like domain family B member 1 Human genes 0.000 claims description 6
- 102100040919 Polycomb group RING finger protein 2 Human genes 0.000 claims description 6
- 101710092205 Polycomb group RING finger protein 2 Proteins 0.000 claims description 6
- 102100040168 Pre-B-cell leukemia transcription factor 2 Human genes 0.000 claims description 6
- 101710170162 Pre-B-cell leukemia transcription factor 2 Proteins 0.000 claims description 6
- 102100024857 Prickle-like protein 4 Human genes 0.000 claims description 6
- 101710099584 Procollagen-lysine,2-oxoglutarate 5-dioxygenase Proteins 0.000 claims description 6
- 102000011195 Profilin Human genes 0.000 claims description 6
- 108050001408 Profilin Proteins 0.000 claims description 6
- 102100026957 Protein FAM214A Human genes 0.000 claims description 6
- 102100021487 Protein S100-B Human genes 0.000 claims description 6
- 102100034207 Protein argonaute-2 Human genes 0.000 claims description 6
- 102100025681 Putative uncharacterized protein PRO0628 Human genes 0.000 claims description 6
- 102000009572 RNA Polymerase II Human genes 0.000 claims description 6
- 108010009460 RNA Polymerase II Proteins 0.000 claims description 6
- 102100031429 Ras-interacting protein 1 Human genes 0.000 claims description 6
- 102100025009 Ras-related GTP-binding protein C Human genes 0.000 claims description 6
- 101710094757 Ras-related GTP-binding protein C Proteins 0.000 claims description 6
- 102100033200 Rho guanine nucleotide exchange factor 7 Human genes 0.000 claims description 6
- 108090000986 Ribosomal protein L10 Proteins 0.000 claims description 6
- 102000004282 Ribosomal protein S9 Human genes 0.000 claims description 6
- 108090000878 Ribosomal protein S9 Proteins 0.000 claims description 6
- 102100031581 SPARC-like protein 1 Human genes 0.000 claims description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- 102100032796 Semaphorin-6B Human genes 0.000 claims description 6
- 102100021119 Serine protease HTRA1 Human genes 0.000 claims description 6
- 102100029710 Serine/arginine-rich splicing factor 6 Human genes 0.000 claims description 6
- 101710123515 Serine/arginine-rich splicing factor 6 Proteins 0.000 claims description 6
- 102000054750 Sm-like protein Lsm7 Human genes 0.000 claims description 6
- 108700035667 Sm-like protein Lsm7 Proteins 0.000 claims description 6
- 102000004598 Small Nuclear Ribonucleoproteins Human genes 0.000 claims description 6
- 108010003165 Small Nuclear Ribonucleoproteins Proteins 0.000 claims description 6
- 102100030510 Stanniocalcin-2 Human genes 0.000 claims description 6
- 101710142154 Stanniocalcin-2 Proteins 0.000 claims description 6
- 102100035604 Synaptopodin Human genes 0.000 claims description 6
- 101710119889 Synaptopodin Proteins 0.000 claims description 6
- 208000031673 T-Cell Cutaneous Lymphoma Diseases 0.000 claims description 6
- 102100026430 Transcription elongation factor A protein 1 Human genes 0.000 claims description 6
- 102100030628 Transcription factor 25 Human genes 0.000 claims description 6
- 102100036676 Transcription initiation factor TFIID subunit 11 Human genes 0.000 claims description 6
- 102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 claims description 6
- 102100027218 Tumor protein p53-inducible nuclear protein 2 Human genes 0.000 claims description 6
- 108091026822 U6 spliceosomal RNA Proteins 0.000 claims description 6
- 102100036638 Unconventional myosin-Id Human genes 0.000 claims description 6
- 102100029827 Unconventional myosin-X Human genes 0.000 claims description 6
- 108010019092 Uridine phosphorylase Proteins 0.000 claims description 6
- 102100020892 Uridine phosphorylase 1 Human genes 0.000 claims description 6
- 210000001766 X chromosome Anatomy 0.000 claims description 6
- 101001053511 Xenopus tropicalis Dihydropyrimidinase-related protein 3 Proteins 0.000 claims description 6
- 210000002593 Y chromosome Anatomy 0.000 claims description 6
- 230000002378 acidificating effect Effects 0.000 claims description 6
- 230000001348 anti-glioma Effects 0.000 claims description 6
- 208000016704 atypical Gaucher disease due to saposin C deficiency Diseases 0.000 claims description 6
- 208000035269 cancer or benign tumor Diseases 0.000 claims description 6
- 201000007241 cutaneous T cell lymphoma Diseases 0.000 claims description 6
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims description 6
- 102000028416 insulin-like growth factor binding Human genes 0.000 claims description 6
- 108091022911 insulin-like growth factor binding Proteins 0.000 claims description 6
- 102000043253 matrix Gla protein Human genes 0.000 claims description 6
- 108010057546 matrix Gla protein Proteins 0.000 claims description 6
- 108010041596 mitogen-activated protein kinase kinase kinase 11 Proteins 0.000 claims description 6
- 201000005962 mycosis fungoides Diseases 0.000 claims description 6
- 210000000107 myocyte Anatomy 0.000 claims description 6
- 108010057248 oncogene proteins v-ets Proteins 0.000 claims description 6
- 230000002018 overexpression Effects 0.000 claims description 6
- 208000025638 primary cutaneous T-cell non-Hodgkin lymphoma Diseases 0.000 claims description 6
- 208000023958 prostate neoplasm Diseases 0.000 claims description 6
- 108010092955 ribosomal protein S16 Proteins 0.000 claims description 6
- 108010093046 ribosomal protein S19 Proteins 0.000 claims description 6
- 108010067528 ribosomal proteins L27 Proteins 0.000 claims description 6
- 210000001685 thyroid gland Anatomy 0.000 claims description 6
- 230000014621 translational initiation Effects 0.000 claims description 6
- 230000005945 translocation Effects 0.000 claims description 6
- 102100039759 von Willebrand factor A domain-containing protein 1 Human genes 0.000 claims description 6
- 229960001134 von willebrand factor Drugs 0.000 claims description 6
- 102100022406 60S ribosomal protein L10a Human genes 0.000 claims description 5
- 108091006112 ATPases Proteins 0.000 claims description 5
- 102100021636 Actin-related protein 2/3 complex subunit 2 Human genes 0.000 claims description 5
- 102000057290 Adenosine Triphosphatases Human genes 0.000 claims description 5
- 102100026341 Beta-1,4-galactosyltransferase 3 Human genes 0.000 claims description 5
- 102100033601 Collagen alpha-1(I) chain Human genes 0.000 claims description 5
- 102100023263 Cyclin-dependent kinase 10 Human genes 0.000 claims description 5
- 102100039455 Cytochrome b-c1 complex subunit 6, mitochondrial Human genes 0.000 claims description 5
- 102100035890 Delta(24)-sterol reductase Human genes 0.000 claims description 5
- 101710154532 Delta(24)-sterol reductase Proteins 0.000 claims description 5
- 102100033299 Glia-derived nexin Human genes 0.000 claims description 5
- 101000755323 Homo sapiens 60S ribosomal protein L10a Proteins 0.000 claims description 5
- 101000754220 Homo sapiens Actin-related protein 2/3 complex subunit 2 Proteins 0.000 claims description 5
- 101000766180 Homo sapiens Beta-1,4-galactosyltransferase 3 Proteins 0.000 claims description 5
- 101000945357 Homo sapiens Collagen alpha-1(I) chain Proteins 0.000 claims description 5
- 101000908138 Homo sapiens Cyclin-dependent kinase 10 Proteins 0.000 claims description 5
- 101000746783 Homo sapiens Cytochrome b-c1 complex subunit 6, mitochondrial Proteins 0.000 claims description 5
- 101000997803 Homo sapiens Glia-derived nexin Proteins 0.000 claims description 5
- 101000650669 Homo sapiens Histone-lysine N-methyltransferase SETD5 Proteins 0.000 claims description 5
- 101000777670 Homo sapiens Hsp90 co-chaperone Cdc37 Proteins 0.000 claims description 5
- 101001054725 Homo sapiens Inhibin beta B chain Proteins 0.000 claims description 5
- 101001011755 Homo sapiens Integrator complex subunit 7 Proteins 0.000 claims description 5
- 101001022948 Homo sapiens LIM domain-binding protein 2 Proteins 0.000 claims description 5
- 101001063370 Homo sapiens Legumain Proteins 0.000 claims description 5
- 101000754911 Homo sapiens Serine/threonine-protein kinase RIO3 Proteins 0.000 claims description 5
- 101000635938 Homo sapiens Transforming growth factor beta-1 proprotein Proteins 0.000 claims description 5
- 101000638886 Homo sapiens Urokinase-type plasminogen activator Proteins 0.000 claims description 5
- 101000785684 Homo sapiens Zinc finger protein 513 Proteins 0.000 claims description 5
- 102100031568 Hsp90 co-chaperone Cdc37 Human genes 0.000 claims description 5
- 102100035957 Huntingtin-interacting protein 1 Human genes 0.000 claims description 5
- 108050003304 Huntingtin-interacting protein 1 Proteins 0.000 claims description 5
- 102100027003 Inhibin beta B chain Human genes 0.000 claims description 5
- 102100030147 Integrator complex subunit 7 Human genes 0.000 claims description 5
- 102100035113 LIM domain-binding protein 2 Human genes 0.000 claims description 5
- 102100027919 Latexin Human genes 0.000 claims description 5
- 101710148080 Latexin Proteins 0.000 claims description 5
- 102100030985 Legumain Human genes 0.000 claims description 5
- 102100032514 MARCKS-related protein Human genes 0.000 claims description 5
- 101710136868 MARCKS-related protein Proteins 0.000 claims description 5
- 241000124008 Mammalia Species 0.000 claims description 5
- 102000002072 Non-Receptor Type 1 Protein Tyrosine Phosphatase Human genes 0.000 claims description 5
- 108010015847 Non-Receptor Type 1 Protein Tyrosine Phosphatase Proteins 0.000 claims description 5
- 102000013817 Ribosomal protein L13 Human genes 0.000 claims description 5
- 108050003655 Ribosomal protein L13 Proteins 0.000 claims description 5
- 241000283984 Rodentia Species 0.000 claims description 5
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 5
- 102100022109 Serine/threonine-protein kinase RIO3 Human genes 0.000 claims description 5
- 102000040945 Transcription factor Human genes 0.000 claims description 5
- 108091023040 Transcription factor Proteins 0.000 claims description 5
- 102100030742 Transforming growth factor beta-1 proprotein Human genes 0.000 claims description 5
- 102100031358 Urokinase-type plasminogen activator Human genes 0.000 claims description 5
- 102100026525 Zinc finger protein 513 Human genes 0.000 claims description 5
- 230000001086 cytosolic effect Effects 0.000 claims description 5
- 230000007812 deficiency Effects 0.000 claims description 5
- 210000003743 erythrocyte Anatomy 0.000 claims description 5
- 230000006846 excision repair Effects 0.000 claims description 5
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 5
- 230000008439 repair process Effects 0.000 claims description 5
- 230000011664 signaling Effects 0.000 claims description 5
- 210000003462 vein Anatomy 0.000 claims description 5
- 102100033756 39S ribosomal protein L45, mitochondrial Human genes 0.000 claims description 4
- 102100036792 Adhesion G protein-coupled receptor L4 Human genes 0.000 claims description 4
- 101710096346 Adhesion G protein-coupled receptor L4 Proteins 0.000 claims description 4
- 102100031611 Collagen alpha-1(III) chain Human genes 0.000 claims description 4
- 102100025877 Complement component C1q receptor Human genes 0.000 claims description 4
- 206010058314 Dysplasia Diseases 0.000 claims description 4
- 102100039950 Eukaryotic initiation factor 4A-I Human genes 0.000 claims description 4
- 108091006027 G proteins Proteins 0.000 claims description 4
- 102000030782 GTP binding Human genes 0.000 claims description 4
- 108091000058 GTP-Binding Proteins 0.000 claims description 4
- 101000733888 Homo sapiens 39S ribosomal protein L45, mitochondrial Proteins 0.000 claims description 4
- 101000993285 Homo sapiens Collagen alpha-1(III) chain Proteins 0.000 claims description 4
- 101000933665 Homo sapiens Complement component C1q receptor Proteins 0.000 claims description 4
- 101000959666 Homo sapiens Eukaryotic initiation factor 4A-I Proteins 0.000 claims description 4
- 101001078149 Homo sapiens Integrin alpha-10 Proteins 0.000 claims description 4
- 101000874532 Homo sapiens Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase Proteins 0.000 claims description 4
- 101000979227 Homo sapiens NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial Proteins 0.000 claims description 4
- 101000685923 Homo sapiens Protein transport protein Sec24A Proteins 0.000 claims description 4
- 101000577874 Homo sapiens Stromelysin-2 Proteins 0.000 claims description 4
- 102100039255 Huntingtin-interacting protein K Human genes 0.000 claims description 4
- 101710159477 Huntingtin-interacting protein K Proteins 0.000 claims description 4
- 102100025310 Integrin alpha-10 Human genes 0.000 claims description 4
- 108010022222 Integrin beta1 Proteins 0.000 claims description 4
- 102000012355 Integrin beta1 Human genes 0.000 claims description 4
- 102100035655 Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase Human genes 0.000 claims description 4
- 102000004058 Leukemia inhibitory factor Human genes 0.000 claims description 4
- 108090000581 Leukemia inhibitory factor Proteins 0.000 claims description 4
- 201000009342 Limb-girdle muscular dystrophy Diseases 0.000 claims description 4
- 102100024177 Microtubule-associated proteins 1A/1B light chain 3B Human genes 0.000 claims description 4
- 101710171597 Microtubule-associated proteins 1A/1B light chain 3B Proteins 0.000 claims description 4
- 102100023212 NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial Human genes 0.000 claims description 4
- 108700026244 Open Reading Frames Proteins 0.000 claims description 4
- 108010077077 Osteonectin Proteins 0.000 claims description 4
- 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 claims description 4
- 102100023368 Protein transport protein Sec24A Human genes 0.000 claims description 4
- 102100037599 SPARC Human genes 0.000 claims description 4
- 102000014105 Semaphorin Human genes 0.000 claims description 4
- 108050003978 Semaphorin Proteins 0.000 claims description 4
- 239000012190 activator Substances 0.000 claims description 4
- 230000001093 anti-cancer Effects 0.000 claims description 4
- 231100000599 cytotoxic agent Toxicity 0.000 claims description 4
- 210000002472 endoplasmic reticulum Anatomy 0.000 claims description 4
- 210000004940 nucleus Anatomy 0.000 claims description 4
- 108020000494 protein-tyrosine phosphatase Proteins 0.000 claims description 4
- 238000010186 staining Methods 0.000 claims description 4
- 238000013518 transcription Methods 0.000 claims description 4
- 230000035897 transcription Effects 0.000 claims description 4
- 102100026189 Beta-galactosidase Human genes 0.000 claims description 3
- 229940121672 Glycosylation inhibitor Drugs 0.000 claims description 3
- 101000715711 Homo sapiens Ceramide kinase Proteins 0.000 claims description 3
- 101000829725 Homo sapiens Phospholipid hydroperoxide glutathione peroxidase Proteins 0.000 claims description 3
- 101000687549 Homo sapiens Prickle-like protein 4 Proteins 0.000 claims description 3
- 101000892326 Homo sapiens Transmembrane protein 184B Proteins 0.000 claims description 3
- 108010076497 Matrix Metalloproteinase 10 Proteins 0.000 claims description 3
- 108010033024 Phospholipid Hydroperoxide Glutathione Peroxidase Proteins 0.000 claims description 3
- 102100040670 Transmembrane protein 184B Human genes 0.000 claims description 3
- 102100040636 Zinc finger protein 84 Human genes 0.000 claims description 3
- 101710160486 Zinc finger protein 84 Proteins 0.000 claims description 3
- 230000002159 abnormal effect Effects 0.000 claims description 3
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 3
- 229940127089 cytotoxic agent Drugs 0.000 claims description 3
- 239000002619 cytotoxin Substances 0.000 claims description 3
- 210000005260 human cell Anatomy 0.000 claims description 3
- 230000005764 inhibitory process Effects 0.000 claims description 3
- 230000003993 interaction Effects 0.000 claims description 3
- 210000001700 mitochondrial membrane Anatomy 0.000 claims description 3
- 230000002285 radioactive effect Effects 0.000 claims description 3
- 229940124597 therapeutic agent Drugs 0.000 claims description 3
- 238000001262 western blot Methods 0.000 claims description 3
- 241000244203 Caenorhabditis elegans Species 0.000 claims description 2
- 101710112752 Cytotoxin Proteins 0.000 claims description 2
- 108010089760 Electron Transport Complex I Proteins 0.000 claims description 2
- 102000008013 Electron Transport Complex I Human genes 0.000 claims description 2
- 102000028180 Glycophorins Human genes 0.000 claims description 2
- 108091005250 Glycophorins Proteins 0.000 claims description 2
- 101000837845 Homo sapiens Transcription factor E3 Proteins 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- 101000913650 Mus musculus Fibronectin type III domain-containing protein 4 Proteins 0.000 claims description 2
- 102000012479 Serine Proteases Human genes 0.000 claims description 2
- 108010022999 Serine Proteases Proteins 0.000 claims description 2
- 102100028507 Transcription factor E3 Human genes 0.000 claims description 2
- 210000000349 chromosome Anatomy 0.000 claims description 2
- 230000006378 damage Effects 0.000 claims description 2
- 239000000032 diagnostic agent Substances 0.000 claims description 2
- 229940039227 diagnostic agent Drugs 0.000 claims description 2
- 208000032839 leukemia Diseases 0.000 claims description 2
- 230000003458 metachromatic effect Effects 0.000 claims description 2
- 238000002493 microarray Methods 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 101150015999 sec24 gene Proteins 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- 102100036721 Insulin receptor Human genes 0.000 claims 5
- 101000578949 Homo sapiens MAP7 domain-containing protein 1 Proteins 0.000 claims 4
- 101000740107 Homo sapiens Equilibrative nucleobase transporter 1 Proteins 0.000 claims 3
- 101000913658 Homo sapiens Fibronectin type III domain-containing protein 4 Proteins 0.000 claims 3
- 108700032475 Sex-Determining Region Y Proteins 0.000 claims 3
- 102100022978 Sex-determining region Y protein Human genes 0.000 claims 3
- 102100040247 Tumor necrosis factor Human genes 0.000 claims 3
- 230000020509 sex determination Effects 0.000 claims 3
- 206010003694 Atrophy Diseases 0.000 claims 2
- 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 claims 2
- 101001125026 Homo sapiens Nucleotide-binding oligomerization domain-containing protein 2 Proteins 0.000 claims 2
- 101000583233 Homo sapiens Pleckstrin homology domain-containing family J member 1 Proteins 0.000 claims 2
- 241000255777 Lepidoptera Species 0.000 claims 2
- LFTYTUAZOPRMMI-CFRASDGPSA-N UDP-N-acetyl-alpha-D-glucosamine Chemical compound O1[C@H](CO)[C@@H](O)[C@H](O)[C@@H](NC(=O)C)[C@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-CFRASDGPSA-N 0.000 claims 2
- LFTYTUAZOPRMMI-UHFFFAOYSA-N UNPD164450 Natural products O1C(CO)C(O)C(O)C(NC(=O)C)C1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-UHFFFAOYSA-N 0.000 claims 2
- 230000037444 atrophy Effects 0.000 claims 2
- 102000028718 growth factor binding proteins Human genes 0.000 claims 2
- 108091009353 growth factor binding proteins Proteins 0.000 claims 2
- 238000003018 immunoassay Methods 0.000 claims 2
- 230000002055 immunohistochemical effect Effects 0.000 claims 2
- 238000012544 monitoring process Methods 0.000 claims 2
- 230000001681 protective effect Effects 0.000 claims 2
- 235000002020 sage Nutrition 0.000 claims 2
- 108010059616 Activins Proteins 0.000 claims 1
- 102000005606 Activins Human genes 0.000 claims 1
- 102000016736 Cyclin Human genes 0.000 claims 1
- 108050006400 Cyclin Proteins 0.000 claims 1
- 108010024882 Electron Transport Complex III Proteins 0.000 claims 1
- 102000015782 Electron Transport Complex III Human genes 0.000 claims 1
- 102100037362 Fibronectin Human genes 0.000 claims 1
- 108010067306 Fibronectins Proteins 0.000 claims 1
- 102000002464 Galactosidases Human genes 0.000 claims 1
- 108010093031 Galactosidases Proteins 0.000 claims 1
- 201000005405 Hermansky-Pudlak syndrome 4 Diseases 0.000 claims 1
- 102100028715 Hermansky-Pudlak syndrome 4 protein Human genes 0.000 claims 1
- 101000884275 Homo sapiens Endosialin Proteins 0.000 claims 1
- 101000985501 Homo sapiens Hermansky-Pudlak syndrome 4 protein Proteins 0.000 claims 1
- 101001052384 Homo sapiens MICAL-like protein 2 Proteins 0.000 claims 1
- 101000609255 Homo sapiens Plasminogen activator inhibitor 1 Proteins 0.000 claims 1
- 101000651439 Homo sapiens Prothrombin Proteins 0.000 claims 1
- 101001130471 Homo sapiens Ras-interacting protein 1 Proteins 0.000 claims 1
- 101000836173 Homo sapiens Tumor protein p53-inducible nuclear protein 2 Proteins 0.000 claims 1
- 101000667353 Homo sapiens von Willebrand factor A domain-containing protein 1 Proteins 0.000 claims 1
- 108010086428 NADH Dehydrogenase Proteins 0.000 claims 1
- 102000006746 NADH Dehydrogenase Human genes 0.000 claims 1
- 241000244206 Nematoda Species 0.000 claims 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 claims 1
- 108010068204 Peptide Elongation Factors Proteins 0.000 claims 1
- 102000002508 Peptide Elongation Factors Human genes 0.000 claims 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 claims 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 claims 1
- 108010001267 Protein Subunits Proteins 0.000 claims 1
- 102000002067 Protein Subunits Human genes 0.000 claims 1
- 102100027378 Prothrombin Human genes 0.000 claims 1
- 102100035772 Regulator of G-protein signaling 12 Human genes 0.000 claims 1
- 101710148337 Regulator of G-protein signaling 12 Proteins 0.000 claims 1
- 102100031396 Schwannomin-interacting protein 1 Human genes 0.000 claims 1
- 101710112816 Schwannomin-interacting protein 1 Proteins 0.000 claims 1
- 101150001027 Suco gene Proteins 0.000 claims 1
- HSCJRCZFDFQWRP-ABVWGUQPSA-N UDP-alpha-D-galactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-ABVWGUQPSA-N 0.000 claims 1
- HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 claims 1
- 239000000488 activin Substances 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000013595 glycosylation Effects 0.000 claims 1
- 238000006206 glycosylation reaction Methods 0.000 claims 1
- 208000032197 kyphoscoliotic type 1 Ehlers-Danlos syndrome Diseases 0.000 claims 1
- 230000036457 multidrug resistance Effects 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 208000003174 Brain Neoplasms Diseases 0.000 abstract description 15
- 230000001772 anti-angiogenic effect Effects 0.000 abstract description 7
- 238000011161 development Methods 0.000 abstract description 5
- 230000001613 neoplastic effect Effects 0.000 abstract description 4
- 238000011282 treatment Methods 0.000 abstract description 4
- 230000005747 tumor angiogenesis Effects 0.000 abstract description 2
- 230000003211 malignant effect Effects 0.000 abstract 1
- 238000003196 serial analysis of gene expression Methods 0.000 description 27
- 239000000047 product Substances 0.000 description 26
- 239000000523 sample Substances 0.000 description 25
- 230000033115 angiogenesis Effects 0.000 description 22
- 230000006870 function Effects 0.000 description 18
- 210000001072 colon Anatomy 0.000 description 15
- 241000699666 Mus <mouse, genus> Species 0.000 description 12
- 208000029742 colonic neoplasm Diseases 0.000 description 10
- 229940079593 drug Drugs 0.000 description 10
- 230000002792 vascular Effects 0.000 description 10
- 102000003746 Insulin Receptor Human genes 0.000 description 9
- 239000011324 bead Substances 0.000 description 9
- 201000011510 cancer Diseases 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 230000012010 growth Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 241000700159 Rattus Species 0.000 description 8
- 230000004614 tumor growth Effects 0.000 description 8
- 102100021866 Hepatocyte growth factor Human genes 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 229940000406 drug candidate Drugs 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 210000005166 vasculature Anatomy 0.000 description 7
- 108010078791 Carrier Proteins Proteins 0.000 description 6
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 6
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 6
- 101000856606 Homo sapiens GTP-binding protein GEM Proteins 0.000 description 6
- 230000008499 blood brain barrier function Effects 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 230000003834 intracellular effect Effects 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000283707 Capra Species 0.000 description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 5
- 102100022427 Plasmalemma vesicle-associated protein Human genes 0.000 description 5
- 230000002163 immunogen Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 108010082117 matrigel Proteins 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 102000002022 plexin Human genes 0.000 description 5
- 108050009312 plexin Proteins 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 108700012359 toxins Proteins 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102100022337 Integrin alpha-V Human genes 0.000 description 4
- 108010040765 Integrin alphaV Proteins 0.000 description 4
- 102000003960 Ligases Human genes 0.000 description 4
- 108090000364 Ligases Proteins 0.000 description 4
- 241000699660 Mus musculus Species 0.000 description 4
- 101100121657 Mus musculus Gem gene Proteins 0.000 description 4
- 101710193105 Plasmalemma vesicle-associated protein Proteins 0.000 description 4
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 4
- 101001089018 Ulex europaeus Anti-H(O) lectin 1 Proteins 0.000 description 4
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 4
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 210000001218 blood-brain barrier Anatomy 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 210000004924 lung microvascular endothelial cell Anatomy 0.000 description 4
- 230000003278 mimic effect Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 238000011830 transgenic mouse model Methods 0.000 description 4
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 3
- 102000010637 Aquaporins Human genes 0.000 description 3
- 108010063290 Aquaporins Proteins 0.000 description 3
- 206010003571 Astrocytoma Diseases 0.000 description 3
- 108091005539 Brain-specific angiogenesis inhibitors Proteins 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 101710193519 Glial fibrillary acidic protein Proteins 0.000 description 3
- 101001139134 Homo sapiens Krueppel-like factor 4 Proteins 0.000 description 3
- 101000663639 Homo sapiens Kunitz-type protease inhibitor 2 Proteins 0.000 description 3
- 102100020677 Krueppel-like factor 4 Human genes 0.000 description 3
- 102100039020 Kunitz-type protease inhibitor 2 Human genes 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 108090000829 Ribosome Inactivating Proteins Proteins 0.000 description 3
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 3
- 239000004037 angiogenesis inhibitor Substances 0.000 description 3
- 239000005557 antagonist Substances 0.000 description 3
- 210000004781 brain capillary Anatomy 0.000 description 3
- 230000000112 colonic effect Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000010437 gem Substances 0.000 description 3
- 238000007901 in situ hybridization Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 230000010412 perfusion Effects 0.000 description 3
- 238000003757 reverse transcription PCR Methods 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 231100000588 tumorigenic Toxicity 0.000 description 3
- 230000000381 tumorigenic effect Effects 0.000 description 3
- 239000013603 viral vector Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 2
- 108050008792 Atypical chemokine receptor 3 Proteins 0.000 description 2
- 102100022716 Atypical chemokine receptor 3 Human genes 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 108090000994 Catalytic RNA Proteins 0.000 description 2
- 102000053642 Catalytic RNA Human genes 0.000 description 2
- 102000005572 Cathepsin A Human genes 0.000 description 2
- 108010059081 Cathepsin A Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 102000053171 Glial Fibrillary Acidic Human genes 0.000 description 2
- 102000042092 Glucose transporter family Human genes 0.000 description 2
- 108091052347 Glucose transporter family Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 101100125778 Homo sapiens IGHM gene Proteins 0.000 description 2
- 101000587539 Homo sapiens Metallothionein-1A Proteins 0.000 description 2
- 101000620348 Homo sapiens Plasmalemma vesicle-associated protein Proteins 0.000 description 2
- 101000933604 Homo sapiens Protein BTG2 Proteins 0.000 description 2
- 102100039352 Immunoglobulin heavy constant mu Human genes 0.000 description 2
- 102100020873 Interleukin-2 Human genes 0.000 description 2
- 108010002350 Interleukin-2 Proteins 0.000 description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 2
- 102000003939 Membrane transport proteins Human genes 0.000 description 2
- 108090000301 Membrane transport proteins Proteins 0.000 description 2
- 201000011442 Metachromatic leukodystrophy Diseases 0.000 description 2
- 102100029698 Metallothionein-1A Human genes 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000272144 Naja atra Species 0.000 description 2
- 108010032605 Nerve Growth Factor Receptors Proteins 0.000 description 2
- 102100028762 Neuropilin-1 Human genes 0.000 description 2
- 108090000772 Neuropilin-1 Proteins 0.000 description 2
- 108091005461 Nucleic proteins Proteins 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 102100026034 Protein BTG2 Human genes 0.000 description 2
- 108010029485 Protein Isoforms Proteins 0.000 description 2
- 102000001708 Protein Isoforms Human genes 0.000 description 2
- 108010076504 Protein Sorting Signals Proteins 0.000 description 2
- 238000002123 RNA extraction Methods 0.000 description 2
- 102000002278 Ribosomal Proteins Human genes 0.000 description 2
- 108010000605 Ribosomal Proteins Proteins 0.000 description 2
- 108010039491 Ricin Proteins 0.000 description 2
- 240000003186 Stachytarpheta cayennensis Species 0.000 description 2
- 235000009233 Stachytarpheta cayennensis Nutrition 0.000 description 2
- 239000006180 TBST buffer Substances 0.000 description 2
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 2
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 2
- 101710102828 Vesicle-associated protein Proteins 0.000 description 2
- 230000009102 absorption Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002491 angiogenic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 210000001130 astrocyte Anatomy 0.000 description 2
- 238000011717 athymic nude mouse Methods 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000030570 cellular localization Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 210000005046 glial fibrillary acidic protein Anatomy 0.000 description 2
- 208000005017 glioblastoma Diseases 0.000 description 2
- 102000053685 human GEM Human genes 0.000 description 2
- 238000003364 immunohistochemistry Methods 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 238000010841 mRNA extraction Methods 0.000 description 2
- 230000036210 malignancy Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 229960000485 methotrexate Drugs 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 102000021160 microtubule binding proteins Human genes 0.000 description 2
- 108091011150 microtubule binding proteins Proteins 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 210000004498 neuroglial cell Anatomy 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 210000004248 oligodendroglia Anatomy 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 2
- 208000030761 polycystic kidney disease Diseases 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 108091092562 ribozyme Proteins 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 210000005239 tubule Anatomy 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 230000003827 upregulation Effects 0.000 description 2
- 229960005356 urokinase Drugs 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
- 101150084750 1 gene Proteins 0.000 description 1
- PNDPGZBMCMUPRI-HVTJNCQCSA-N 10043-66-0 Chemical compound [131I][131I] PNDPGZBMCMUPRI-HVTJNCQCSA-N 0.000 description 1
- WUAPFZMCVAUBPE-NJFSPNSNSA-N 188Re Chemical compound [188Re] WUAPFZMCVAUBPE-NJFSPNSNSA-N 0.000 description 1
- 102100036652 26S proteasome non-ATPase regulatory subunit 8 Human genes 0.000 description 1
- 101150033839 4 gene Proteins 0.000 description 1
- 101710187785 60S ribosomal protein L1-A Proteins 0.000 description 1
- 101710187786 60S ribosomal protein L1-B Proteins 0.000 description 1
- 108010066676 Abrin Proteins 0.000 description 1
- 102100023989 Actin-related protein 2 Human genes 0.000 description 1
- 108090000963 Actin-related protein 2 Proteins 0.000 description 1
- 102000003741 Actin-related protein 3 Human genes 0.000 description 1
- 108090000104 Actin-related protein 3 Proteins 0.000 description 1
- 102000009840 Angiopoietins Human genes 0.000 description 1
- 108010009906 Angiopoietins Proteins 0.000 description 1
- 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
- 102000030431 Asparaginyl endopeptidase Human genes 0.000 description 1
- 241000351920 Aspergillus nidulans Species 0.000 description 1
- 241000228254 Aspergillus restrictus Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 102100028699 C-type lectin domain family 4 member E Human genes 0.000 description 1
- UJKPHYRXOLRVJJ-MLSVHJFASA-N CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C Chemical compound CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C UJKPHYRXOLRVJJ-MLSVHJFASA-N 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 101000678889 Canis lupus familiaris Atypical chemokine receptor 3 Proteins 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 102000003727 Caveolin 1 Human genes 0.000 description 1
- 108090000026 Caveolin 1 Proteins 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 238000003734 CellTiter-Glo Luminescent Cell Viability Assay Methods 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 108091028732 Concatemer Proteins 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- WEAHRLBPCANXCN-UHFFFAOYSA-N Daunomycin Natural products CCC1(O)CC(OC2CC(N)C(O)C(C)O2)c3cc4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1 WEAHRLBPCANXCN-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- BDCFUHIWJODVNG-UHFFFAOYSA-N Desmosterol Natural products C1C=C2CC(O)C=CC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 BDCFUHIWJODVNG-UHFFFAOYSA-N 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 102000016607 Diphtheria Toxin Human genes 0.000 description 1
- 108010053187 Diphtheria Toxin Proteins 0.000 description 1
- 241000251948 Dolophilodes major Species 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 101710082714 Exotoxin A Proteins 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108050009401 Fibronectin type III Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 101150066002 GFP gene Proteins 0.000 description 1
- 108700004714 Gelonium multiflorum GEL Proteins 0.000 description 1
- 241000720950 Gluta Species 0.000 description 1
- 102100039993 Hairy/enhancer-of-split related with YRPW motif-like protein Human genes 0.000 description 1
- 102100024025 Heparanase Human genes 0.000 description 1
- 241001272567 Hominoidea Species 0.000 description 1
- 101001136717 Homo sapiens 26S proteasome non-ATPase regulatory subunit 8 Proteins 0.000 description 1
- 101001000001 Homo sapiens Basement membrane-specific heparan sulfate proteoglycan core protein Proteins 0.000 description 1
- 101000766921 Homo sapiens C-type lectin domain family 4 member E Proteins 0.000 description 1
- 101001035082 Homo sapiens Hairy/enhancer-of-split related with YRPW motif-like protein Proteins 0.000 description 1
- 101001081412 Homo sapiens Heme transporter HRG1 Proteins 0.000 description 1
- 101000753197 Homo sapiens Sodium/potassium-transporting ATPase subunit alpha-2 Proteins 0.000 description 1
- 101001028730 Homo sapiens Transcription factor JunB Proteins 0.000 description 1
- 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 208000005168 Intussusception Diseases 0.000 description 1
- 101150105382 MET gene Proteins 0.000 description 1
- 102000003792 Metallothionein Human genes 0.000 description 1
- 108090000157 Metallothionein Proteins 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 101100190817 Mus musculus Plvap gene Proteins 0.000 description 1
- 206010061309 Neoplasm progression Diseases 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 108010036505 Neutral Amino Acid Transport Systems Proteins 0.000 description 1
- 102000012106 Neutral Amino Acid Transport Systems Human genes 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 102000007999 Nuclear Proteins Human genes 0.000 description 1
- 108010089610 Nuclear Proteins Proteins 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000282579 Pan Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 231100000742 Plant toxin Toxicity 0.000 description 1
- 108010001014 Plasminogen Activators Proteins 0.000 description 1
- 102000001938 Plasminogen Activators Human genes 0.000 description 1
- 108010077971 Plasminogen Inactivators Proteins 0.000 description 1
- 102000010752 Plasminogen Inactivators Human genes 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 101800001295 Putative ATP-dependent helicase Proteins 0.000 description 1
- 101800001006 Putative helicase Proteins 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 238000010240 RT-PCR analysis Methods 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- 240000003946 Saponaria officinalis Species 0.000 description 1
- 108010084592 Saporins Proteins 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- 229940122055 Serine protease inhibitor Drugs 0.000 description 1
- 101710102218 Serine protease inhibitor Proteins 0.000 description 1
- 241000710960 Sindbis virus Species 0.000 description 1
- 102100021955 Sodium/potassium-transporting ATPase subunit alpha-2 Human genes 0.000 description 1
- 102100039485 Symplekin Human genes 0.000 description 1
- 101710138921 Symplekin Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 102100037168 Transcription factor JunB Human genes 0.000 description 1
- 102000006747 Transforming Growth Factor alpha Human genes 0.000 description 1
- 101800004564 Transforming growth factor alpha Proteins 0.000 description 1
- 241000009298 Trigla lyra Species 0.000 description 1
- 108091026838 U1 spliceosomal RNA Proteins 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- VWQVUPCCIRVNHF-OUBTZVSYSA-N Yttrium-90 Chemical compound [90Y] VWQVUPCCIRVNHF-OUBTZVSYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- REDXJYDRNCIFBQ-UHFFFAOYSA-N aluminium(3+) Chemical compound [Al+3] REDXJYDRNCIFBQ-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003527 anti-angiogenesis Effects 0.000 description 1
- 238000011122 anti-angiogenic therapy Methods 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000000074 antisense oligonucleotide Substances 0.000 description 1
- 238000012230 antisense oligonucleotides Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 108010055066 asparaginylendopeptidase Proteins 0.000 description 1
- VJBCNMFKFZIXHC-UHFFFAOYSA-N azanium;2-(4-methyl-5-oxo-4-propan-2-yl-1h-imidazol-2-yl)quinoline-3-carboxylate Chemical compound N.N1C(=O)C(C(C)C)(C)N=C1C1=NC2=CC=CC=C2C=C1C(O)=O VJBCNMFKFZIXHC-UHFFFAOYSA-N 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- JCXGWMGPZLAOME-AKLPVKDBSA-N bismuth-212 Chemical compound [212Bi] JCXGWMGPZLAOME-AKLPVKDBSA-N 0.000 description 1
- JCXGWMGPZLAOME-RNFDNDRNSA-N bismuth-213 Chemical compound [213Bi] JCXGWMGPZLAOME-RNFDNDRNSA-N 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 201000007983 brain glioma Diseases 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000003163 breast adenoma Diseases 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 229960004562 carboplatin Drugs 0.000 description 1
- 190000008236 carboplatin Chemical compound 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000004323 caveolae Anatomy 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 230000008568 cell cell communication Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 238000001516 cell proliferation assay Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000015114 central nervous system disease Diseases 0.000 description 1
- 208000025997 central nervous system neoplasm Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 229960000975 daunorubicin Drugs 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- AVSXSVCZWQODGV-DPAQBDIFSA-N desmosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@@H](CCC=C(C)C)C)[C@@]1(C)CC2 AVSXSVCZWQODGV-DPAQBDIFSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 230000009274 differential gene expression Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 229960004679 doxorubicin Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 229960003569 hematoporphyrin Drugs 0.000 description 1
- 108010037536 heparanase Proteins 0.000 description 1
- 208000029824 high grade glioma Diseases 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000036732 histological change Effects 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000037451 immune surveillance Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 238000013388 immunohistochemistry analysis Methods 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000126 in silico method Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010249 in-situ analysis Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000008606 intracellular interaction Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 201000011614 malignant glioma Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004084 membrane receptors Proteins 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 210000004897 n-terminal region Anatomy 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000007511 neuronal proliferation Effects 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000003076 paracrine Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 238000002428 photodynamic therapy Methods 0.000 description 1
- 239000003123 plant toxin Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 230000033885 plasminogen activation Effects 0.000 description 1
- 229940127126 plasminogen activator Drugs 0.000 description 1
- 239000002797 plasminogen activator inhibitor Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001023 pro-angiogenic effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002213 purine nucleotide Substances 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000024769 regulation of transport Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- WUAPFZMCVAUBPE-IGMARMGPSA-N rhenium-186 Chemical compound [186Re] WUAPFZMCVAUBPE-IGMARMGPSA-N 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000003001 serine protease inhibitor Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000004960 subcellular localization Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001578 tight junction Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 102000027257 transmembrane receptors Human genes 0.000 description 1
- 108091008578 transmembrane receptors Proteins 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 239000000439 tumor marker Substances 0.000 description 1
- 230000005751 tumor progression Effects 0.000 description 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 description 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 201000011531 vascular cancer Diseases 0.000 description 1
- 230000006459 vascular development Effects 0.000 description 1
- 230000006444 vascular growth Effects 0.000 description 1
- 206010055031 vascular neoplasm Diseases 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000007998 vessel formation Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40339002P | 2002-08-15 | 2002-08-15 | |
| US45897803P | 2003-04-01 | 2003-04-01 | |
| PCT/US2003/025614 WO2004016758A2 (en) | 2002-08-15 | 2003-08-15 | Brain endothelial cell expression patterns |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010127374A Division JP2010284161A (ja) | 2002-08-15 | 2010-06-03 | 脳内皮細胞発現パターン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006512924A true JP2006512924A (ja) | 2006-04-20 |
| JP2006512924A5 JP2006512924A5 (enExample) | 2007-02-15 |
Family
ID=31891381
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005502059A Withdrawn JP2006512924A (ja) | 2002-08-15 | 2003-08-15 | 脳内皮細胞発現パターン |
| JP2010127374A Pending JP2010284161A (ja) | 2002-08-15 | 2010-06-03 | 脳内皮細胞発現パターン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010127374A Pending JP2010284161A (ja) | 2002-08-15 | 2010-06-03 | 脳内皮細胞発現パターン |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US20060127902A1 (enExample) |
| EP (2) | EP2236614A3 (enExample) |
| JP (2) | JP2006512924A (enExample) |
| AU (1) | AU2003262717A1 (enExample) |
| WO (1) | WO2004016758A2 (enExample) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012522756A (ja) * | 2009-04-03 | 2012-09-27 | フンダシオ プリバーダ インスティトゥシオ カタラナ デ レセルカ イ エストゥディス アバンカッツ | 望ましくない細胞増殖と関連する疾患の治療のための治療剤 |
| JP2013523796A (ja) * | 2010-04-05 | 2013-06-17 | フンダシオ プリバーダ インスティトゥト ディンベスティガシオ オンコロジカ バル デブロン（ウベアチェイーオー） | ヒト白血病阻害因子（ｌｉｆ）を認識する抗体および望ましくない細胞増殖に関連する疾患の治療における抗ｌｉｆ抗体の使用 |
| JP2018511569A (ja) * | 2015-02-16 | 2018-04-26 | キシンテラ、アクチボラグＸｉｎｔｅｌａ Ａｂ | 中枢神経系における悪性腫瘍の検出及び治療 |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7569342B2 (en) | 1997-12-10 | 2009-08-04 | Sierra Molecular Corp. | Removal of molecular assay interferences |
| US20030114410A1 (en) * | 2000-08-08 | 2003-06-19 | Technion Research And Development Foundation Ltd. | Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis |
| WO2004064785A2 (en) | 2003-01-14 | 2004-08-05 | Dana Farber Cancer Institute | Cancer therapy sensitizer |
| WO2005059109A2 (en) * | 2003-12-15 | 2005-06-30 | The Regents Of The University Of California | Molecular signature of the pten tumor suppressor |
| AU2004305075A1 (en) * | 2003-12-19 | 2005-07-07 | The Regents Of The University Of California | Methods and materials for assessing prostate cancer therapies |
| NZ550102A (en) * | 2004-02-24 | 2010-10-29 | Univ California | Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives) |
| CA2585719A1 (en) * | 2004-11-08 | 2006-05-18 | Schering Corporation | Tumor association of mdl-1 and methods |
| AU2006241235B2 (en) | 2005-04-22 | 2012-04-05 | Eisai, Inc. | Antibodies with immune effector activity and that internalize in endosialin-positive cells |
| US7709517B2 (en) * | 2005-05-13 | 2010-05-04 | The Regents Of The University Of California | Diarylhydantoin compounds |
| WO2006128063A2 (en) * | 2005-05-25 | 2006-11-30 | Irm Llc | Methods and compositions for inhibiting glioma growth |
| US20070225242A1 (en) * | 2005-06-21 | 2007-09-27 | The Board Of Trustees Of The Leland Stanford Junior University | Method and composition for treating and preventing tumor metastasis in vivo |
| US20070021365A1 (en) * | 2005-06-21 | 2007-01-25 | The Board Of Trustees Of The Leland Stanford Junior University | Inhibition of Lysyl oxidase for treating tumor growth and diagnostics relating thereto |
| WO2007009816A2 (en) | 2005-07-21 | 2007-01-25 | Stichting Katholieke Universiteit | Plexin d1 as a target for tumor diagnosis and therapy |
| EP1937831B1 (en) * | 2005-09-27 | 2012-08-01 | University of Saskatchewan | Use of n-myristoyltransferase on non-tumor tissue for cancer diagnosis |
| WO2007107774A2 (en) * | 2006-03-22 | 2007-09-27 | Cartela R & D Ab | Integrin alpha-10 subunit as therapeutic target and diagnostic/prognostic marker for cancer |
| DK2656842T3 (en) * | 2006-03-27 | 2016-11-07 | Univ California | Androgen receptor MODULATOR FOR THE TREATMENT OF PROSTATE CANCER AND androgen receptor-ASSOCIATED DISEASES |
| EP3020706A1 (en) | 2006-03-29 | 2016-05-18 | The Regents Of The University Of California | Diarylthiohydantoin compounds useful for the treatment of a hyperproliferative disorder |
| CA2669260C (en) | 2006-11-09 | 2019-01-15 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Differential gene expression in physiological and pathological angiogenesis |
| EP2117591A4 (en) * | 2007-01-22 | 2010-11-17 | Mayo Foundation | REDUCING TUMOR GROWTH |
| ES2452929T3 (es) * | 2007-04-05 | 2014-04-03 | Morphotek, Inc. | Métodos para inhibir la unión de endosialina a ligandos |
| EA200700940A1 (ru) | 2007-04-27 | 2007-12-28 | Петр Генриевич ЛОХОВ | Способ получения противоопухолевой вакцины на основе поверхностных антигенов эндотелиальных клеток |
| KR20230117256A (ko) | 2007-07-23 | 2023-08-07 | 더 차이니즈 유니버시티 오브 홍콩 | 대규모 병렬 게놈 서열분석을 이용한 태아 염색체 이수성의진단 방법 |
| US12180549B2 (en) | 2007-07-23 | 2024-12-31 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using genomic sequencing |
| US8679485B2 (en) | 2007-08-02 | 2014-03-25 | Gilead Biologics, Inc. | Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis |
| EP2220050A2 (en) | 2007-10-26 | 2010-08-25 | The Regents Of The University Of California | Diarylhydantoin compounds as androgen receptor modulators |
| DE102008011850A1 (de) | 2008-02-29 | 2009-09-03 | Michael Grzendowski | Biomarker für die Diagnose von Hirntumor |
| EP3115063A3 (en) | 2008-12-03 | 2017-04-19 | The John Hopkins University | Galectin-3 and annexin-a2 as immunological target |
| WO2010080769A2 (en) * | 2009-01-06 | 2010-07-15 | Arresto Biosciences, Inc. | Chemotherapeutic methods and compositions |
| KR101054952B1 (ko) * | 2009-01-22 | 2011-08-05 | 재단법인 한국원자력의학원 | 간암 진단 및 환자 생존기간 예측용 마커인 ｕｑｃｒｈ, 그를 포함하는 키트 및 상기 마커를 이용한 간암 환자 생존기간 예측 |
| US20100260769A1 (en) * | 2009-04-09 | 2010-10-14 | Morphotek, Inc. | Endosialin binding molecules |
| AU2010284000A1 (en) * | 2009-08-21 | 2012-03-22 | Gilead Biologics, Inc. | In vitro screening assays |
| EP2467396A4 (en) | 2009-08-21 | 2012-12-26 | Gilead Biologics Inc | CATALYTIC DOMAINS FROM LYSYL OXIDASE AND LOXL2 |
| US20110044907A1 (en) * | 2009-08-21 | 2011-02-24 | Derek Marshall | In vivo screening assays |
| CN102711821A (zh) * | 2009-08-21 | 2012-10-03 | 吉联亚生物科技有限公司 | 治疗方法和组合物 |
| CN102711839A (zh) * | 2009-08-21 | 2012-10-03 | 吉联亚生物科技有限公司 | 体内筛选试验 |
| CN105622757A (zh) | 2010-02-04 | 2016-06-01 | 吉联亚生物科技有限公司 | 结合赖氨酰氧化酶样2（loxl2）的抗体和其使用方法 |
| AU2011218173C1 (en) | 2010-02-16 | 2015-04-16 | Aragon Pharmaceuticals, Inc. | Androgen receptor modulators and uses thereof |
| US20130330349A1 (en) | 2011-02-23 | 2013-12-12 | Rappaport Family Institute For Research In The Medical Sciences | High affinity molecules capable of binding a type a plexin receptor and uses of same |
| US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
| IL312316A (en) | 2012-09-26 | 2024-06-01 | Aragon Pharmaceuticals Inc | Antiandrogens for the treatment of castration-resistant prostate cancer without metastases |
| JOP20200097A1 (ar) | 2013-01-15 | 2017-06-16 | Aragon Pharmaceuticals Inc | معدل مستقبل أندروجين واستخداماته |
| KR101727026B1 (ko) * | 2014-03-06 | 2017-04-17 | (주)노바셀테크놀로지 | 신규 신경교종의 바이오마커 및 그의 용도 |
| KR101644599B1 (ko) | 2014-10-14 | 2016-08-16 | 연세대학교 산학협력단 | 미토콘드리아 단백질 uqcrb 관련 질환 유전자발현 세포 구축 및 이를 활용한 uqcrb 기능조절 활성평가계 구축 |
| US10364467B2 (en) | 2015-01-13 | 2019-07-30 | The Chinese University Of Hong Kong | Using size and number aberrations in plasma DNA for detecting cancer |
| TWI726969B (zh) | 2016-01-11 | 2021-05-11 | 比利時商健生藥品公司 | 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物 |
| JOP20200076A1 (ar) | 2017-10-16 | 2020-04-30 | Aragon Pharmaceuticals Inc | مضادات أندروجين لعلاج سرطان البروستاتا غير النقيلي المقاوم للاستئصال |
| CN110687236B (zh) * | 2019-10-30 | 2022-05-17 | 陕西师范大学 | 基于iTRAQ标记蛋白评价肉类冻融程度的方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6194158B1 (en) * | 1998-11-12 | 2001-02-27 | Nyxis Neurotherapies, Inc. | Diagnostic assay for cancer |
| US6335170B1 (en) * | 1999-02-22 | 2002-01-01 | Torben F. Orntoft | Gene expression in bladder tumors |
| WO2002047535A2 (en) * | 2000-12-14 | 2002-06-20 | Nyxis Neurotherapies, Inc. | High throughput assay to detect inhibitors of the map kinase pathway |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6075181A (en) | 1990-01-12 | 2000-06-13 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US20020015950A1 (en) * | 1999-07-07 | 2002-02-07 | Karen Anne Jones | Atherosclerosis-associated genes |
| AU2001283062A1 (en) * | 2000-08-02 | 2002-02-13 | The Johns Hopkins University | Endothelial cell expression patterns |
| TW200413725A (en) * | 2002-09-30 | 2004-08-01 | Oncotherapy Science Inc | Method for diagnosing non-small cell lung cancers |
| US20070292423A1 (en) * | 2003-04-08 | 2007-12-20 | Masaaki Oka | Method of Defining the Differentiation Grade of Tumor |
-
2003
- 2003-08-15 JP JP2005502059A patent/JP2006512924A/ja not_active Withdrawn
- 2003-08-15 US US10/524,432 patent/US20060127902A1/en not_active Abandoned
- 2003-08-15 EP EP20100168014 patent/EP2236614A3/en not_active Ceased
- 2003-08-15 WO PCT/US2003/025614 patent/WO2004016758A2/en not_active Ceased
- 2003-08-15 EP EP03788531A patent/EP1576131A4/en not_active Withdrawn
- 2003-08-15 AU AU2003262717A patent/AU2003262717A1/en not_active Abandoned
-
2009
- 2009-11-11 US US12/616,600 patent/US20100062002A1/en not_active Abandoned
-
2010
- 2010-06-03 JP JP2010127374A patent/JP2010284161A/ja active Pending
-
2012
- 2012-07-09 US US13/544,631 patent/US20120308479A1/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6194158B1 (en) * | 1998-11-12 | 2001-02-27 | Nyxis Neurotherapies, Inc. | Diagnostic assay for cancer |
| US6335170B1 (en) * | 1999-02-22 | 2002-01-01 | Torben F. Orntoft | Gene expression in bladder tumors |
| WO2002047535A2 (en) * | 2000-12-14 | 2002-06-20 | Nyxis Neurotherapies, Inc. | High throughput assay to detect inhibitors of the map kinase pathway |
Non-Patent Citations (6)
| Title |
|---|
| JPN6009023970, "Ｄｉｆｆｅｒｅｎｔｉａｔｉｏｎ", ２００１， Ｖｏｌ．６８， ｐｐ．１４１−１５２ * |
| JPN6009023973, "Ｐｒｏｃｅｅｄｉｎｇｓ ｏｆ ｔｈｅ Ｎａｔｉｏｎａｌ Ａｃａｄｅｍｙ ｏｆ Ｓｃｉｅｎｃｅｓ ｏｆ ＵＳＡ", ２００１， Ｖｏｌ．９８， Ｎｏ．１９， ｐｐ．１０８５１−１０８５６ * |
| JPN6009023976, "Ｎａｔｕｒｅ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ", Ｍａｙ ２００２， Ｖｏｌ．２０， ｐｐ．５０８−５１２ * |
| JPN6009023978, "Ｎａｔｕｒｅ Ｇｅｎｅｔｉｃｓ", １９９９， Ｖｏｌ．２３， ｐｐ．３８７−３８８ * |
| JPN6009023980, "Ｎｕｃｌｅｉｃ Ａｃｉｄｓ Ｒｅｓｅａｒｃｈ", １９９９， Ｖｏｌ．２７， Ｎｏ．５， ｐｐ．１３００−１３０７ * |
| JPN6009023983, "Ｂｉｏｃｈｅｍｉｃａｌ ａｎｄ Ｂｉｏｐｈｙｓｉｃａｌ Ｒｅｓｅａｒｃｈ Ｃｏｍｍｕｎｉｃａｔｉｏｎｓ", ２０００， Ｖｏｌ．２７５， ｐｐ．１０８−１１４ * |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012522756A (ja) * | 2009-04-03 | 2012-09-27 | フンダシオ プリバーダ インスティトゥシオ カタラナ デ レセルカ イ エストゥディス アバンカッツ | 望ましくない細胞増殖と関連する疾患の治療のための治療剤 |
| JP2016040255A (ja) * | 2009-04-03 | 2016-03-24 | フンダシオ プリバーダ インスティトゥシオ カタラナ デ レセルカ イ エストゥディス アバンカッツ | 望ましくない細胞増殖と関連する疾患の治療のための治療剤 |
| JP2019006784A (ja) * | 2009-04-03 | 2019-01-17 | フンダシオ プリバーダ インスティトゥシオ カタラナ デ レセルカ イ エストゥディス アバンカッツ | 望ましくない細胞増殖と関連する疾患の治療のための治療剤 |
| JP2020090522A (ja) * | 2009-04-03 | 2020-06-11 | フンダシオ プリバーダ インスティトゥシオ カタラナ デ レセルカ イ エストゥディス アバンカッツ | 望ましくない細胞増殖と関連する疾患の治療のための治療剤 |
| JP2022031742A (ja) * | 2009-04-03 | 2022-02-22 | フンダシオ プリバーダ インスティトゥシオ カタラナ デ レセルカ イ エストゥディス アバンカッツ | 望ましくない細胞増殖と関連する疾患の治療のための治療剤 |
| JP7197665B2 (ja) | 2009-04-03 | 2022-12-27 | フンダシオ プリバーダ インスティトゥシオ カタラナ デ レセルカ イ エストゥディス アバンカッツ | 望ましくない細胞増殖と関連する疾患の治療のための治療剤 |
| JP2013523796A (ja) * | 2010-04-05 | 2013-06-17 | フンダシオ プリバーダ インスティトゥト ディンベスティガシオ オンコロジカ バル デブロン（ウベアチェイーオー） | ヒト白血病阻害因子（ｌｉｆ）を認識する抗体および望ましくない細胞増殖に関連する疾患の治療における抗ｌｉｆ抗体の使用 |
| JP2017019775A (ja) * | 2010-04-05 | 2017-01-26 | フンダシオ プリバーダ インスティトゥト ディンベスティガシオ オンコロジカ バル デブロン（ウベアチェイーオー） | ヒト白血病阻害因子（ｌｉｆ）を認識する抗体および望ましくない細胞増殖に関連する疾患の治療における抗ｌｉｆ抗体の使用 |
| JP2018511569A (ja) * | 2015-02-16 | 2018-04-26 | キシンテラ、アクチボラグＸｉｎｔｅｌａ Ａｂ | 中枢神経系における悪性腫瘍の検出及び治療 |
| JP2021073237A (ja) * | 2015-02-16 | 2021-05-13 | キシンテラ、アクチボラグＸｉｎｔｅｌａ Ａｂ | 中枢神経系における悪性腫瘍の検出及び治療 |
| JP7059478B2 (ja) | 2015-02-16 | 2022-04-26 | タージンタ アクチエボラグ | 中枢神経系における悪性腫瘍の検出及び治療 |
| JP7139569B2 (ja) | 2015-02-16 | 2022-09-21 | タージンタ アクチエボラグ | 中枢神経系における悪性腫瘍の検出及び治療 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003262717A1 (en) | 2004-03-03 |
| AU2003262717A8 (en) | 2004-03-03 |
| EP2236614A3 (en) | 2011-01-26 |
| JP2010284161A (ja) | 2010-12-24 |
| WO2004016758A3 (en) | 2006-03-02 |
| WO2004016758A2 (en) | 2004-02-26 |
| US20100062002A1 (en) | 2010-03-11 |
| EP2236614A2 (en) | 2010-10-06 |
| EP1576131A2 (en) | 2005-09-21 |
| EP1576131A4 (en) | 2008-08-13 |
| US20060127902A1 (en) | 2006-06-15 |
| US20120308479A1 (en) | 2012-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006512924A (ja) | 脳内皮細胞発現パターン | |
| Madden et al. | Vascular gene expression in nonneoplastic and malignant brain | |
| JP5969538B2 (ja) | 診断および治療のための腫瘍関連細胞表面抗原の同定 | |
| Kislin et al. | NHERF-1: modulator of glioblastoma cell migration and invasion | |
| US20050214831A1 (en) | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer | |
| US7799518B2 (en) | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer | |
| JP2007518399A (ja) | 肺癌を診断および治療する組成物並びに方法 | |
| AU2011250588C1 (en) | Method for the diagnosis of epithelial cancers by the detection of EpICD polypeptide | |
| US20120252022A1 (en) | Methods and compositions for the diagnosis and treatment of thyroid cancer | |
| JP2008546387A (ja) | 癌を処置および診断するための組成物および方法 | |
| JP2006526992A (ja) | 癌を検出し、癌の進行をモニタリングする方法 | |
| JP2016525883A (ja) | 腺癌を予後的に分類及び治療する方法 | |
| JP2004533825A (ja) | 内皮細胞発現パターンの評価法 | |
| WO2004005883A2 (en) | Secreted and cytoplasmic tumor endothelial markers | |
| KR101492024B1 (ko) | 전이성 뇌종양 진단용 마커 | |
| US7871788B2 (en) | Method of judging grade of malignancy of carcinoma cell using ATBF-1 | |
| JPH08500731A (ja) | 診断法 | |
| WO2010050268A1 (ja) | がん幹細胞分子マーカー | |
| EP4650779A1 (en) | Biomarker for diagnosis or prognosis of squamous cell lung carcinoma using exosomes and use thereof | |
| KR102401005B1 (ko) | 고위험군 자궁내막증의 예방 또는 치료용 조성물 | |
| EP1774026A2 (en) | Differential expression of genes in microsatellite instability | |
| KR101925715B1 (ko) | 간암 예후측정 또는 진단용 마커로서의 ard1의 용도 | |
| KR20160096841A (ko) | 간암의 진단 또는 예후 바이오 마커 및 그의 용도 | |
| KR20240109655A (ko) | 담도암 진단용 바이오마커 | |
| KR101755792B1 (ko) | 암 진단 또는 예후 추정용 바이오 마커 및 그의 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060807 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061220 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090520 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090818 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090825 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091120 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100203 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100603 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100712 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20100713 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100720 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20100810 |
|
| A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20101015 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20130313 |